Eli Lilly’s Zepbound eases obstructive sleep apnea in trials
Eli Lilly reported positive results of its obesity drug Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity
Eli Lilly reported positive results of its obesity drug Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity
Tacalyx was founded in 2019 as a spin-out of the Max-Planck-Institute of Colloids and Interfaces (MPICI) in Potsdam, Germany. Credit: Lightspring / Shutterstock. Cancer-focused biotech
A polyphenol-rich cranberry beverage was found to improve skin elasticity, reduce UV-induced erythema, and modulate the skin microbiome, with effects most pronounced in women aged